AssureImmune merges with BCU

Jun 16 2010

AssureImmune LLC (AI), the premier family stem cell bank in the United States, today announced their merger with Banco de Cordón Umbilical (BCU), the largest cord blood bank in Latin America. This merger expands the Companies' global reach providing family stem cell banking services to North, Central and South America. With state-of-the-art automated equipment and laboratories for processing, testing and storage in the U.S., Mexico and Brazil, the new organization is well positioned to become the leading family stem cell bank in the Americas.

“We are very excited about this groundbreaking opportunity to expand into the U.S. market as well as to offer stem cell banking services to older children and adults, who did not have the opportunity to bank their cord blood stem cells”

There are over 70 diseases that can be treated with stem cells, including leukemia, anemia, blood cancers, and immune system dysfunctions. Currently, there are over 400 clinical trials underway in the U.S. in final Phase III. These clinical trials are focused on new ways of safely and effectively using stem cells to treat, and potentially cure, cardiovascular diseases, autoimmune diseases, diabetes, cancer, orthopedic conditions, and more.

With more than 50 offices in the Americas, tens of thousands of satisfied customers and several successful transplants, BCU has positioned itself as the premier Cord Blood Bank in this market. "We are very excited about this groundbreaking opportunity to expand into the U.S. market as well as to offer stem cell banking services to older children and adults, who did not have the opportunity to bank their cord blood stem cells," states Teodoro Myslabodski, BCU's President & CEO.

"This merger brings together two companies committed to excellence and state-of-the-art facilities providing AI the opportunity to expand into the Latin American market. The new organization is well equipped to execute our comprehensive business development, marketing and operations efforts in order to expand our stem cell collection services not only to Latin America but worldwide," states Javier Zylberberg, AI's President & CEO.

Featuring advanced testing methods and high quality processing and storage services, including the fully automated, technologically advanced AXP® and BioArchive® Systems, the new organization, with over 15 years of combined experience, has a mission to become a world renowned leader in the stem cell and cryopreservation market.